The 2017 Access to Vaccines Index has mapped how vaccine companies are responding to global calls to improve immunisation coverage. The companies approach access to vaccines in differing ways, which are generally linked to their diverseĀ pipelines, portfolios, revenues and sales.

The Index covers three Research Areas: Research & Development, Pricing & Registration; and Manufacturing & Supply. These are the three areas where vaccine companies have a critical role to play to improve access to vaccines.

Research & Development

Research & Development

The Access to Vaccines Index analyses the R&D projects for preventive vaccines of eight companies in the following areas: R&D investments, Vaccine pipelines, Types of vaccine R&D and Access provisions
Continue reading
Pricing & Registration

Pricing & Registration

The Access to Vaccines Index evaluates data from six companies in relation to vaccine pricing and registration in the following areas: Vaccine pricing decisions, Price trends, Transparency in pricing and Availability.
Continue reading
Manufacturing & Supply

Manufacturing & Supply

The Access to Vaccines Index examines six companiesā€™ activities in relation to the manufacture and supply of vaccines in the following areas: Aligning supply and demand, Capacity building and Distribution and administration.
Continue reading

Sign up to receive updates about our work.